NightHawk Biosciences Inc (NHWK)

[dave86]

Heat Biologics, Inc. (the “Company”) previously reported in a Form 8-K filed on February 23, 2016 with the Securities and Exchange Commission (the “SEC”) that the Company had received written notice on February 22, 2016 from the NASDAQ Stock Market LLC (“Nasdaq”) indicating that, as of December 31, 2015 the Company’s reported stockholders’ equity of $2,495,000 did not meet the $2,500,000 minimum required to maintain continued listing, as set forth in NASDAQ Listing Rule 5550(b)(1), and that as of February 22, 2016 the Company did not meet the alternatives of market value of listed securities or net income from continuing operations. The Nasdaq notice further stated that pursuant to Nasdaq rules the Company was required to submit to Nasdaq a plan to regain compliance no later than April 7, 2016.